CAD 0.24
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 21.97 Million CAD | 24.7% |
2022 | 17.61 Million CAD | -21.0% |
2021 | 22.3 Million CAD | -26.04% |
2020 | 30.15 Million CAD | -33.23% |
2019 | 45.16 Million CAD | 60.27% |
2018 | 28.18 Million CAD | 1230.88% |
2017 | 2.11 Million CAD | 2176.82% |
2016 | 93 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 19.36 Million CAD | -10.07% |
2024 Q1 | 21.53 Million CAD | -1.98% |
2023 Q4 | 21.97 Million CAD | -11.07% |
2023 FY | 21.97 Million CAD | 24.7% |
2023 Q3 | 24.7 Million CAD | 11.65% |
2023 Q2 | 22.13 Million CAD | 23.98% |
2023 Q1 | 17.85 Million CAD | 1.31% |
2022 Q1 | 26.29 Million CAD | 17.91% |
2022 FY | 17.61 Million CAD | -21.0% |
2022 Q4 | 17.61 Million CAD | -19.35% |
2022 Q3 | 21.84 Million CAD | -4.58% |
2022 Q2 | 22.89 Million CAD | -12.93% |
2021 Q3 | 27.36 Million CAD | 1.52% |
2021 FY | 22.3 Million CAD | -26.04% |
2021 Q2 | 26.95 Million CAD | -11.19% |
2021 Q1 | 30.34 Million CAD | 0.64% |
2021 Q4 | 22.3 Million CAD | -18.49% |
2020 Q2 | 42.53 Million CAD | -5.56% |
2020 FY | 30.15 Million CAD | -33.23% |
2020 Q1 | 45.04 Million CAD | -0.27% |
2020 Q4 | 30.15 Million CAD | -20.36% |
2020 Q3 | 37.86 Million CAD | -10.99% |
2019 Q2 | 47.51 Million CAD | 60.21% |
2019 FY | 45.16 Million CAD | 60.27% |
2019 Q1 | 29.66 Million CAD | 5.25% |
2019 Q3 | 43.29 Million CAD | -8.88% |
2019 Q4 | 45.16 Million CAD | 4.31% |
2018 Q1 | - CAD | -100.0% |
2018 Q4 | 28.18 Million CAD | 229.06% |
2018 Q3 | 8.56 Million CAD | 0.0% |
2018 FY | 28.18 Million CAD | 1230.88% |
2017 FY | 2.11 Million CAD | 2176.82% |
2017 Q4 | 2.11 Million CAD | 0.0% |
2016 FY | 93 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aurora Cannabis Inc. | 838.67 Million CAD | 97.38% |
Avant Brands Inc. | 82.55 Million CAD | 73.385% |
Cardiol Therapeutics Inc. | 36.7 Million CAD | 40.134% |
Crescita Therapeutics Inc. | 24.59 Million CAD | 10.679% |
Knight Therapeutics Inc. | 945.49 Million CAD | 97.676% |
MediPharm Labs Corp. | 63.93 Million CAD | 65.636% |
OrganiGram Holdings Inc. | 298.45 Million CAD | 92.638% |
Canopy Growth Corporation | 1.3 Billion CAD | 98.31% |
Willow Biosciences Inc. | 6.67 Million CAD | -229.254% |
Auxly Cannabis Group Inc. | 261.9 Million CAD | 91.611% |